|
Office of Acquisition & Logistics
|
National Acquisition Center - Federal Supply Schedule Service - Pharmaceuticals - Incentives
Pharmaceutical Incentives
| Contractor |
Products |
Description of Programs |
Effective Date |
Expiration Date |
| Abbott |
Depakote ER (SA) |
Market Share |
5/1/2006 |
12/31/2008 |
| Abbott HPD (Medisense) |
Blood glucose prods. |
VISN Formulary |
10/1/2001 |
12/31/2006 |
| Abbott PPD |
Gengraf (Cyclosporine) |
Market share program |
1/1/2002 |
3/31/2006 |
| Abbottx PPD (Medisense) |
Depakote ER (SA) |
Market Share & Formulary Placement |
5/15/2001 |
12/31/2006 |
| Abbottx PPD (Medisense) |
Synthroid |
Market Share |
8/15/2006 |
12/31/2006 |
| Abbott PPD (Medisense) |
Tricor |
Market Share & Formulary Placement |
5/15/2001 |
12/31/2006 |
| Alcon Laboratories |
Patanol (Olopatadine) |
Formulary & Market Share |
7/1/2005 |
6/30/2006 |
| AstraZeneca |
Casodex |
Market Share |
3/1/2004 |
3/31/2006 |
| AstraZeneca |
Seroquel |
Market Share |
3/1/2004 |
3/31/2006 |
| Berlex |
Climara |
Rebate Program |
0701/05 |
6/30/2010 |
| Berlex |
Magnevist and Ultravist |
Rebate Program |
0701/05 |
6/30/2010 |
| Bristol Myers Squibb Pharma |
Coumadin |
Upfront Discount |
8/15/2004 |
12/31/2006 |
| Bristol Myers Squibb US Medicines |
Abilify |
Formulary |
11/15/2004 |
12/31/2006 |
| Bristol Myers Squibb US Medicines |
Avapro & Avalide Tablets |
Market Share |
11/15/2004 |
12/31/2006 |
| Eisai, Inc. |
Aricept |
Market Share |
12/1/2004 |
12/31/2006 |
| Forest Labs |
Aerobid / Aerobid-M |
Market Share |
7/15/2005 |
7/13/2010 |
| Glaxo SmithKline |
Avandia & Avandamet |
Market Share/Formulary Status |
7/1/2005 |
6/30/2007 |
| J&J (Janssen) |
Reminyl/Razadyne |
Market Share |
8/1/2005 |
1/14/2010 |
| J&J (Janssen) |
Risperdal (Risperidone) |
VA Market share program |
1/15/2005 |
1/14/2010 |
| Kremers Urban |
Omeprazole |
Bulk Purchase |
2/1/2005 |
1/31/2010 |
| Merck & Co |
Cozaar/Hyzaar |
Federal Hypertension Management Program (FHMP) |
1/1/2003 |
6/30/2006 |
| Merck & Co |
Fosamax |
Market Share Program |
9/1/2003 |
6/30/2006 |
| Merck & Co |
Proscar |
Market Share |
6/1/2004 |
6/30/2006 |
| Meretek Diagnostics |
Breath Tek Ubit-IR300 |
Lease |
5/1/2006 |
7/14/2011 |
| Merz Pharm |
Naftin Cream |
Performance |
4/1/2004 |
3/31/2009 |
| Novartis Pharma |
Exelon |
Market Share |
1/1/2006 |
12/31/2006 |
| Novartis Pharma |
Lamisil |
Market Share |
1/1/2006 |
12/31/2006 |
| Pfizer |
Gelfoam |
Market Share |
1/1/2006 |
12/31/2006 |
| Pfizer |
Zoloft (SSRIs) |
Formulary Status |
1/1/2006 |
12/31/2006 |
| Pfizer |
Zyrtec |
VISN Formulary |
1/1/2006 |
12/31/2006 |
| Procter & Gamble Pharmacueticals |
Actonel |
Market Share |
3/1/2004 |
3/31/2006 |
| Roche Diagnostics |
Blood Glucose Test Strips |
Performance |
10/1/2001 |
9/30/2006 |
| Sanofi-Synthelabo, Inc. |
Uroxatral |
Formulary status (Equal) |
4/1/2005 |
3/31/2006 |
| Schering Corp |
Foradil |
Market Share |
12/15/2005 |
4/30/2006 |
| Schering Corp |
Asmanex |
Market Share |
1/1/2006 |
12/31/2006 |
| Wyeth |
Zosyn (12 products) |
Market Share Rebate |
11/15/2004 |
11/14/2009 |
| Wyeth |
Zosyn (9 products) |
Market Share Rebate |
11/15/2004 |
11/14/2009 |
|
|
|
|
| Reviewed/Updated Date:
Tuesday, August 21, 2007
|
|